IFT88 has also been shown to inhibit Che1, an inhibitor of the Rb tumor suppressor – upon IFT88 ablation, Che1 then inhibits Rb, freeing E2F transcription factors to drive cell cycle progression [169]. The gene discussed is RB1; the disease is neoplasm.